アモキシシリン細粒20%「TCK」 200mg
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB01060 |
| エビデンスレベル | L5(計算予測のみ) |
| 予測適応症数 | 44 |
| 日本商品名(例) | アモキシシリン細粒20%「TCK」 200mg, ワイドシリン細粒20% 200mg |
承認適応症(KEGG)
淋菌感染症、梅毒、歯周組織炎、猩紅熱、ヘリコバクター・ピロリ感染症
予測適応症(TxGNN)
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | hyperamylasemia | 99% | DL |
| 2 | polyclonal hyperviscosity syndrome | 99% | DL |
| 3 | congenital analbuminemia | 99% | DL |
| 4 | blood group incompatibility | 99% | DL |
| 5 | premalignant hematological system disease | 99% | DL |
| 6 | monoclonal gammopathy | 99% | DL |
| 7 | hematological disease associated with an acquired peripheral neuropathy | 99% | DL |
| 8 | septicemic plague | 99% | DL |
| 9 | congenital hematological disorder | 98% | DL |
| 10 | epiglottitis | 98% | DL |
| 11 | bubonic plague | 97% | DL |
| 12 | laryngitis | 97% | DL |
| 13 | pneumococcal meningitis | 96% | DL |
| 14 | urinary tract infection (disease) | 95% | DL |
| 15 | punctate epithelial keratoconjunctivitis | 95% | DL |
| 16 | pneumonic plague | 95% | DL |
| 17 | gonococcal urethritis | 94% | DL |
| 18 | Ureaplasma urethritis | 94% | DL |
| 19 | staphylococcal pneumonia | 94% | DL |
| 20 | fungal lung infectious disease | 94% | DL |
| 21 | hematopoietic and lymphoid system neoplasm | 94% | DL |
| 22 | laryngeal diphtheria | 94% | DL |
| 23 | silicotuberculosis | 93% | DL |
| 24 | pleural tuberculosis | 93% | DL |
| 25 | acute gonococcal endometritis | 93% | DL |
| 26 | uterine inflammatory disease | 92% | DL |
| 27 | xanthogranulomatous pyelonephritis | 92% | DL |
| 28 | non specific chronic endometritis | 92% | DL |
| 29 | granulomatous endometritis | 92% | DL |
| 30 | pyoureter | 92% | DL |
| 31 | staphylococcus aureus infection | 91% | DL |
| 32 | pyelitis | 91% | DL |
| 33 | urogenital tuberculosis | 90% | DL |
| 34 | endometrial disease | 90% | DL |
| 35 | rhinoscleroma | 89% | DL |
| 36 | streptococcal pneumonia | 87% | DL |
| 37 | streptococcal infection | 86% | DL |
| 38 | bacterial pneumonia | 84% | DL |
| 39 | infectious otitis media | 82% | DL |
| 40 | staphylococcus aureus pneumonia | 59% | DL |
| 41 | Klebsiella pneumonia | 54% | DL |
| 42 | pharyngitis | 48% | DL |
| 43 | staphylococcal infection | 19% | DL |
| 44 | escherichia coli infection | 8% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。